Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
Johnson & Johnson (JNJ) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com? ›
JNJ Stock 12 Month Forecast
What is the forecast for JNJ stock? ›Based on short-term price targets offered by 20 analysts, the average price target for Johnson & Johnson comes to $171.27. The forecasts range from a low of $150.00 to a high of $215.00. The average price target represents an increase of 3.91% from the last closing price of $164.82.
What is the price target for JNJ in 2025? ›According to analysts, JNJ price target is 171.37 USD with a max estimate of 215.00 USD and a min estimate of 150.00 USD.
What is the analyst price target for JNJ? ›| High | $215.00 |
|---|---|
| Median | $170.00 |
| Low | $150.00 |
| Average | $171.37 |
| Current Price | $166.99 |
Johnson & Johnson stock price forecast for September 2024. The forecast for beginning 166 dollars. Maximum price 184, minimum 154. Averaged Johnson & Johnson stock price for the month 168.
Is JNJ a buy hold or sell? ›Is JNJ a Buy, Sell or Hold? Johnson & Johnson has a consensus rating of Moderate Buy which is based on 6 buy ratings, 8 hold ratings and 0 sell ratings.
Where will JNJ stock be in 5 years? ›Highlights and Key Points: JNJ stock Forecast 2024-2030
JNJ assets have consistently grown over the past decade, with projections extending until 2030. Analysts predict the stock could reach $164.77 per share by the end of 2024 with the lowest expected price of $40 and the most optimistic forecast of around $215.
NEW BRUNSWICK, N.J., August 16, 2023 -- Johnson & Johnson (NYSE: JNJ) today announced the final exchange ratio for its previously announced split-off exchange offer to Johnson & Johnson shareholders to exchange their shares of Johnson & Johnson for shares of common stock of Kenvue Inc.
Is JNJ overvalued or undervalued? ›The Numbers Behind JNJ's Undervaluation
As of August 2024, JNJ is trading at $160.56, with a forward P/E ratio of 20.56, which is 33.5% lower than the sector's average of 20.76. Additionally, JNJ's trailing twelve-month (TTM) PEG ratio is 0.58.
As it stands, J&J currently expects to grow its business by 3% next year and then 5% to 7% out through 2030, Taubert said.
What is the target price prediction? ›
What is Target's price target? The average price target for Target is $173.58. This is based on 28 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $209.00 ,the lowest forecast is $116.00.
What is the target analyst forecast? ›Analyst Price Targets
Based on analysts offering 12 month price targets for TGT in the last 3 months. The average price target is $180.87 with a high estimate of $200 and a low estimate of $156.
A price target is a price at which an analyst believes a stock to be fairly valued relative to its projected and historical earnings. When an analyst raises their price target for a stock, they generally expect the stock price to rise.
What is the JNJ stock price forecast for 12 months? ›Based on analysts offering 12 month price targets for JNJ in the last 3 months. The average price target is $172.46 with a high estimate of $215 and a low estimate of $150.
What is the future outlook for Johnson and Johnson? ›Johnson & Johnson Stock Forecast
The 12 analysts with 12-month price forecasts for Johnson & Johnson stock have an average target of 172.42, with a low estimate of 150 and a high estimate of 215. The average target predicts an increase of 3.38% from the current stock price of 166.78.
Our forecast is based on a 17x P/E multiple for JNJ and expected earnings of $10.70 on a per-share and adjusted basis for the full year 2024. The 17x P/E multiple aligns with the average value over the last five years. Johnson & Johnson's revenue of $85.2 billion in 2023 was up 6% y-o-y.
Is JNJ stock going to split? ›Here's a snapshot of the JNJ stock split history: Data source: Johnson & Johnson. Although Johnson & Johnson has no upcoming stock split, the company plans to split into two by spinning off its consumer business (Kenvue) in November 2023.
Is Johnson & Johnson a good stock to buy zacks? ›Currently, Johnson & Johnson is carrying a Zacks Rank of #3 (Hold). From a valuation perspective, Johnson & Johnson is currently exchanging hands at a Forward P/E ratio of 16.52. This expresses a premium compared to the average Forward P/E of 15.97 of its industry.
What is the projected growth of JNJ? ›Future Growth
Johnson & Johnson is forecast to grow earnings and revenue by 8% and 3.4% per annum respectively. EPS is expected to grow by 9.2% per annum. Return on equity is forecast to be 34.6% in 3 years.